Disease Domain | Count |
---|---|
Immune System Diseases | 1 |
Infectious Diseases | 1 |
Top 5 Drug Type | Count |
---|---|
Small molecule drug | 2 |
Top 5 Target | Count |
---|---|
PPARα(Peroxisome proliferator-activated receptor α) | 1 |
Target- |
Mechanism- |
Active Org. |
Originator Org. |
Active Indication |
Inactive Indication- |
Drug Highest PhasePreclinical |
First Approval Ctry. / Loc.- |
First Approval Date- |
Start Date23 Dec 2023 |
Sponsor / Collaborator |
Start Date01 Sep 2023 |
Sponsor / Collaborator |
Start Date21 Jun 2023 |
Sponsor / Collaborator |
Drug(Targets) | Indications | Global Highest Phase |
---|---|---|
GW-7647 ( PPARα ) | Asthma More | Preclinical |
GPI-0039-05 | Bacterial Infections More | Preclinical |